BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$872M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$311M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$169M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$169M |
| 2 |
CELG
Celgene Corp
CELG
|
+$148M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$134M |
| 4 |
State Street SPDR S&P Retail ETF
XRT
|
+$121M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$83.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.64% |
| 2 | Financials | 6.05% |
| 3 | Healthcare | 5.2% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
BGC Group
BGC
$5.2B
| $77.5K | ﹤0.01% |
14,604
+1,961
| +16% | +$11.7K |
|
3152
Turning Point Brands
TPB
$1.73B
| $77.5K | ﹤0.01% |
1,682
+1,681
| +168,100% | +$64.4K |
|
3153
Cytokinetics
CYTK
$10.2B
| $77.4K | ﹤0.01% |
9,571
+9,555
| +59,719% | +$70.2K |
|
3154
Live Oak Bancshares
LOB
$2.01B
| $77.4K | ﹤0.01% |
5,298
+5,289
| +58,767% | +$81.3K |
|
3155
A10 Networks
ATEN
$1.96B
| $76.9K | ﹤0.01% |
10,853
+10,813
| +27,033% | +$73.5K |
|
|
KNOW
3156
DELISTED
Direxion All Cap Insider Sentiment Shares
KNOW
| $76.9K | ﹤0.01% |
2,000
| – | – |
|
3157
CNB Financial Corp
CCNE
$1.04B
| $76.8K | ﹤0.01% |
3,040
+2,584
| +567% | +$67.2K |
|
|
QVCGA
3158
PUT
DELISTED
QVC Group Inc Series A
QVCGA
| $76.7K | ﹤0.01% |
1
| – | – |
|
|
GNMK
3159
DELISTED
GenMark Diagnostics, Inc
GNMK
| $76.5K | ﹤0.01% |
10,791
+10,772
| +56,695% | +$70.9K |
|
3160
Community Health Systems
CYH
$419M
| $76.4K | ﹤0.01% |
20,480
-207,910
| -91% | -$853K |
|
|
DPLO
3161
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $76.1K | ﹤0.01% |
13,104
+10,708
| +447% | +$111K |
|
3162
Old Second Bancorp
OSBC
$1.31B
| $76.1K | ﹤0.01% |
6,046
+5,038
| +500% | +$69.7K |
|
|
TBRG
3163
DELISTED
TruBridge
TBRG
| $76K | ﹤0.01% |
2,561
+1,752
| +217% | +$50.6K |
|
|
GWPH
3164
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $75.9K | ﹤0.01% |
450
-1,644
| -79% | -$245K |
|
|
BSTC
3165
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $75.1K | ﹤0.01% |
1,205
+1,203
| +60,150% | +$79.6K |
|
3166
Willdan Group
WLDN
$1.29B
| $75.1K | ﹤0.01% |
2,026
+2,023
| +67,433% | +$72K |
|
|
ZIXI
3167
DELISTED
Zix Corporation
ZIXI
| $74.8K | ﹤0.01% |
10,875
+10,858
| +63,871% | +$77.7K |
|
3168
Hawkins
HWKN
$2.67B
| $74.7K | ﹤0.01% |
4,054
+3,302
| +439% | +$67.5K |
|
|
FTSI
3169
DELISTED
FTS International, Inc. Common Stock
FTSI
| $74.6K | ﹤0.01% |
373
+270
| +262% | +$48.3K |
|
3170
Caesarstone
CSTE
$105M
| $74.5K | ﹤0.01% |
4,772
+3,984
| +506% | +$62.4K |
|
|
CLVS
3171
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $74.5K | ﹤0.01% |
30
-196
| -87% | -$4.91K |
|
|
EGIO
3172
DELISTED
Edgio, Inc. Common Stock
EGIO
| $74.1K | ﹤0.01% |
574
+569
| +11,380% | +$66.1K |
|
3173
Motorcar Parts of America
MPAA
$235M
| $74.1K | ﹤0.01% |
3,927
+3,158
| +411% | +$62.9K |
|
|
ACR
3174
ACRES Commercial Realty
ACR
$101M
| $74.1K | ﹤0.01% |
2,322
+1,132
| +95% | +$36K |
|
3175
CryoPort
CYRX
$766M
| $74K | ﹤0.01% |
+5,730
| New | +$62.3K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2019 Portfolio in Review
As of Q1 2019, BNP Paribas Financial Markets held 4,541 positions worth $46.3B, up 9.3% from $42.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
BNP Paribas Financial Markets deployed $4.24B of net new capital in Q1 2019, opening 207 new positions and adding to 2,771 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $169M trimmed.
- BNP Paribas Financial Markets's largest Q1 2019 buy was iShares Russell 2000 Growth ETF: 649,500 shares worth $128M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2019, an estimated $1.31B increase.
- BNP Paribas Financial Markets's biggest Q1 2019 reduction was VanEck Gold Miners ETF, cutting an estimated $169M.
- BNP Paribas Financial Markets fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $37.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 17% of its $46.3B portfolio in Q1 2019.
- BNP Paribas Financial Markets opened 207 new positions and closed 255 in Q1 2019.
- BNP Paribas Financial Markets's portfolio value rose 9.3% quarter-over-quarter to $46.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.